Statens Serum Institut   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (1902)

Organization Overview

First Clinical Trial
1989
NCT01353807
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Bandim Health Project, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark | Department of Epidemiology Research, Statens Serum Institut, 2300 Copenhagen S, Denmark | Research Center for Vitamins and Vaccines, Statens Serum Institute | Statens Serum Institut | Statens Serum Institut Denmark | Statens Serum Institute, Research Center for Vitamins and Vaccines, Bandim Health Project | Statens serum Institute/SSI/,Denamrk